Balchem Corp (BCPC) stock
BCPCNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 19/3015% above fair value
$173.14+0.79 (+0.46%)
Close on Nov 13, 2026Market cap $5.50BP/E 32.6Yield 0.55%
Balchem r&d expenses
Research and development expenses are spending on new products and technology.
Balchem's R&D Expenses for the twelve months ending Sep 30, 2026 was $20.81M, up 15.8% year over year. For fiscal 2025 it was $18.51M, up 10.2% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $18.51M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.51M | +10.2% |
| FY2024 | Dec 31, 2024 | $16.79M | +11.6% |
| FY2023 | Dec 31, 2023 | $15.05M | +23.4% |
| FY2022 | Dec 31, 2022 | $12.19M | -9.9% |
| FY2021 | Dec 31, 2021 | $13.52M | +30.9% |
| FY2020 | Dec 31, 2020 | $10.33M | -9.2% |
| FY2019 | Dec 31, 2019 | $11.38M | -1.9% |
| FY2018 | Dec 31, 2018 | $11.59M | +24.6% |
| FY2017 | Dec 31, 2017 | $9.31M | +27.0% |
| FY2016 | Dec 31, 2016 | $7.33M | +22.3% |
| FY2015 | Dec 31, 2015 | $5.99M | +24.5% |
| FY2014 | Dec 31, 2014 | $4.81M | +32.8% |
| FY2013 | Dec 31, 2013 | $3.62M | +5.8% |
| FY2012 | Dec 31, 2012 | $3.42M | +18.4% |
| FY2011 | Dec 31, 2011 | $2.89M | -9.4% |
| FY2010 | Dec 31, 2010 | $3.19M | -3.3% |
| FY2009 | Dec 31, 2009 | $3.30M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.34M | +18.8% |
| Q2 FY2026 | Jun 30, 2026 | $4.53M | +5.4% |
| Q1 FY2026 | Mar 31, 2026 | $5.88M | +26.1% |
| Q4 FY2025 | Dec 31, 2025 | $5.05M | +12.0% |
| Q3 FY2025 | Sep 30, 2025 | $4.50M | +3.9% |
| Q2 FY2025 | Jun 30, 2025 | $4.30M | +11.6% |
| Q1 FY2025 | Mar 31, 2025 | $4.66M | +13.7% |
| Q4 FY2024 | Dec 31, 2024 | $4.51M | +14.6% |
| Q3 FY2024 | Sep 30, 2024 | $4.33M | +11.9% |
| Q2 FY2024 | Jun 30, 2024 | $3.85M | +1.6% |
| Q1 FY2024 | Mar 31, 2024 | $4.10M | +18.8% |
| Q4 FY2023 | Dec 31, 2023 | $3.94M | +29.4% |
| Q3 FY2023 | Sep 30, 2023 | $3.87M | +29.1% |
| Q2 FY2023 | Jun 30, 2023 | $3.80M | +29.9% |
| Q1 FY2023 | Mar 31, 2023 | $3.45M | +6.8% |
| Q4 FY2022 | Dec 31, 2022 | $3.04M | -35.6% |
| Q3 FY2022 | Sep 30, 2022 | $3.00M | -5.1% |
| Q2 FY2022 | Jun 30, 2022 | $2.92M | +0.8% |
| Q1 FY2022 | Mar 31, 2022 | $3.23M | +17.5% |
| Q4 FY2021 | Dec 31, 2021 | $4.72M | +99.1% |
| Q3 FY2021 | Sep 30, 2021 | $3.16M | +17.2% |
| Q2 FY2021 | Jun 30, 2021 | $2.90M | +12.8% |
| Q1 FY2021 | Mar 31, 2021 | $2.75M | +1.8% |
| Q4 FY2020 | Dec 31, 2020 | $2.37M | -19.1% |
| Q3 FY2020 | Sep 30, 2020 | $2.69M | -0.3% |
| Q2 FY2020 | Jun 30, 2020 | $2.57M | -9.9% |
| Q1 FY2020 | Mar 31, 2020 | $2.70M | -6.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.93M | -9.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.70M | +6.3% |
| Q2 FY2019 | Jun 30, 2019 | $2.85M | -11.7% |
| Q1 FY2019 | Mar 31, 2019 | $2.90M | +12.7% |
| Q4 FY2018 | Dec 31, 2018 | $3.25M | +30.2% |
| Q3 FY2018 | Sep 30, 2018 | $2.54M | -6.3% |
| Q2 FY2018 | Jun 30, 2018 | $3.23M | +41.7% |
| Q1 FY2018 | Mar 31, 2018 | $2.57M | +41.5% |
| Q4 FY2017 | Dec 31, 2017 | $2.50M | +40.2% |
| Q3 FY2017 | Sep 30, 2017 | $2.71M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.28M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.82M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.78M | – |
See a number that looks wrong?